Concord Repatriation General /ID# 233467

Concord, New South Wales 2139

0 studies enrolling now · 1 studies all time

What they study most

Crohn's Disease

Studies at this site

• A Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Intravenous (IV) Infusion and Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Crohn's Disease — Stopped early